Handbook

E

Eloralintide

Eloralintide (LY3841136) is a once week weight loss drug. It’s different from GLP-1 drugs like semaglutide and tirzepatide, Eloralintide is a selective amylin receptor agonist, designed mainly to activate the AMY1 receptor.

Amylin is a hormone your body releases after eating. Activating its receptors can increase fullness, decrease hunger, and reduce food intake

Research application

Copied from the handbook as research notes. and not instructions.

  • Eloralintide: Start at 1mg per week and increase as needed 3mg, 6mg, 9mg etc

New Phase 2b trials have combining Eloralintide with tirzepatide the tested regimens included:

  • 3 mg EL + 5 mg tirzepatide
  • 6 mg EL + 5 mg tirzepatide
  • 6 mg EL + 10 mg tirzepatide
  • 9 mg EL + 15 mg tirzepatide

Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes

From @BowTiedYukon

Read this first

The information provided is for educational and informational purposes only and is not medical advice. Always consult with your physician or a qualified healthcare provider before starting any health protocol or using any peptides

YOU assume full responsibility for YOUR actions and decisions. Do YOUR own research and make informed choices in consultation with a licensed medical professional

This guide is an independent work created by the author. It is not affiliated with, endorsed by, or associated with any company or organization

All peptides discussed are intended for research use only. They are not intended for human or animal consumption or for use in any diagnostic or therapeutic purposes

Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes

This app is an alphabetical reader for BowTiedYukon’s free Peptide Handbook. It is not affiliated with Elite Research USA. His profile lists the code YUKON10.

@BowTiedYukon